title: Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy?
authors.forename: G
authors.initials: G
authors.lastname: Robaeys
authors.forename: M C
authors.initials: MC
authors.lastname: Wichers
authors.forename: J
authors.initials: J
authors.lastname: De Bie
authors.forename: G H
authors.initials: GH
authors.lastname: Koek
authors.forename: F
authors.initials: F
authors.lastname: Buntinx
authors.forename: J
authors.initials: J
authors.lastname: Van Os
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects; D003863:Depression / Q000188:drug therapy*; D004347:Drug Interactions; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000998:Antiviral Agents; D016898:Interferon-alpha; D017367:Selective Serotonin Reuptake Inhibitors